Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib/IIa BrainshuttleTM AD study and design of Phase III PrevenTRON study in pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results